Yale University’s NextCure NXTC Stock Holding History

Yale University’s Portfolio NXTC Stock Details NXTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-10,373	Closed	-$3.84M	–	9
2019 Q3	$3.84M	Hold	10,373	–	–	3.16%	5
2019 Q2	$1.86M	Buy	+10,373	New	+$2.16M	1.54%	6

Other funds holding NXTC

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

CPX

Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Yale University's NXTC Position: Q4 2019 in Review

Yale University sold out of NextCure (NXTC) in Q4 2019, closing a stake of 10,373 shares — an estimated $3.84M sold.

Yale University first reported a position in NXTC in Q2 2019 and held it in 2 quarters. The position peaked at $3.84M in Q3 2019. 88 funds tracked by Wall St. Rank hold NXTC as of Q4 2019.

Yale University reported no remaining NextCure position as of Q4 2019 after selling out during the quarter.
Yale University sold 10,373 NextCure shares in Q4 2019, an estimated $3.84M.
Yale University first reported a position in NextCure in Q2 2019 and held it in 2 quarters.
Yale University's NextCure position peaked at $3.84M in Q3 2019.
88 funds tracked by Wall St. Rank held NextCure as of Q4 2019.

Based on Yale University's 13F filing for Q4 2019, filed 13 Feb 2020.